Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 20, Issue 6, Pages 407-408Publisher
NATURE PORTFOLIO
DOI: 10.1038/d41573-021-00074-y
Keywords
-
Funding
- IMI Joint Undertaking from the European Union's Seventh Framework Programme [115583]
- EFPIA companies'
Ask authors/readers for more resources
ENABLE is an antibacterial drug discovery and development consortium formed in 2014 as part of the Innovative Medicines Initiative (IMI) New Drugs for Bad Bugs (ND4BB) programme. With the project soon ending, a brief overview of its achievements, strengths, and weaknesses is provided.
ENABLE is an antibacterial drug discovery and development consortium formed as a publicprivate partnership in 2014 as part of the Innovative Medicines Initiative (IMI) New Drugs for Bad Bugs (ND4BB) programme. With the project soon ending, here we provide a brief overview and reflect on its achievements, strengths and weaknesses.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
